(Q42994469)

12 November 2017

Unscrambling hepatitis C virus-host interactions (English)

1 reference

12 November 2017

1 reference

1 reference

1

1 reference

PubMed ID

16107831

12 November 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

12 November 2017

1 reference

12 November 2017

436

1 reference

12 November 2017

930-932

1 reference

12 November 2017

7053

1 reference

https://scigraph.springernature.com/pub.10.1038/nature04076

12 November 2017

0 references

cites work

Course and outcome of hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Prevention of spread of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Hepatitis C in state correctional facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Viral Internal Ribosome Entry Site Elements: Novel Ribosome-RNA Complexes and Roles in Viral Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Structural biology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Antiviral actions of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Hepatitis C virus replicons: potential role for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Stealth and cunning: hepatitis B and hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Cell-mediated immunity and the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Advances in model systems for hepatitis C virus research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Current therapy for hepatitis C: pegylated interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

Epidemiology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

7 January 2021

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1038%2FNATURE04076

7 January 2021

Identifiers

DOI

10.1038/NATURE04076

1 reference

PubMed ID

16107831

Dimensions Publication ID

12 November 2017

0 references

1 reference

PubMed ID

16107831